TD Asset Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,200
| Closed | -$576K | – | 1406 |
|
|
2024
Q3 | $576K | Buy |
15,200
+3,700
| +32% | +$140K | ﹤0.01% | 1281 |
|
|
2024
Q2 | $520K | Buy |
11,500
+2,400
| +26% | +$109K | ﹤0.01% | 1271 |
|
|
2024
Q1 | $441K | Sell |
9,100
-300
| -3% | -$14.6K | ﹤0.01% | 1314 |
|
|
2023
Q4 | $504K | Buy |
9,400
+800
| +9% | +$42.9K | ﹤0.01% | 1298 |
|
|
2023
Q3 | $504K | Buy |
8,600
+1,200
| +16% | +$70.3K | ﹤0.01% | 1280 |
|
|
2023
Q2 | $466K | Buy |
7,400
+3,400
| +85% | +$214K | ﹤0.01% | 1280 |
|
|
2023
Q1 | $252K | Buy |
+4,000
| New | +$252K | ﹤0.01% | 1360 |
|
|
2022
Q1 | – | Sell |
-9,700
| Closed | -$982K | – | 1512 |
|
|
2021
Q4 | $982K | Sell |
9,700
-21,000
| -68% | -$2.13M | ﹤0.01% | 1276 |
|
|
2021
Q3 | $2.83M | Buy |
30,700
+800
| +3% | +$73.8K | ﹤0.01% | 982 |
|
|
2021
Q2 | $2.85M | Buy |
29,900
+1,400
| +5% | +$133K | ﹤0.01% | 987 |
|
|
2021
Q1 | $2.78M | Hold |
28,500
| – | – | ﹤0.01% | 1005 |
|
|
2020
Q4 | $2.2M | Sell |
28,500
-28,500
| -50% | -$2.2M | ﹤0.01% | 1016 |
|
|
2020
Q3 | $4.2M | Sell |
57,000
-14,000
| -20% | -$1.03M | 0.01% | 747 |
|
|
2020
Q2 | $5.21M | Buy |
71,000
+3,600
| +5% | +$264K | 0.01% | 649 |
|
|
2020
Q1 | $3.89M | Buy |
67,400
+31,200
| +86% | +$1.8M | 0.01% | 674 |
|
|
2019
Q4 | $2.84M | Buy |
+36,200
| New | +$2.84M | ﹤0.01% | 845 |
|